Rhabdomyosarcoma other imaging findings

Jump to navigation Jump to search

Rhabdomyosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Rhabdomyosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Rhabdomyosarcoma other imaging findings On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Rhabdomyosarcoma other imaging findings

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Rhabdomyosarcoma other imaging findings

CDC on Rhabdomyosarcoma other imaging findings

Rhabdomyosarcoma other imaging findings in the news

Blogs on Rhabdomyosarcoma other imaging findings

Directions to Hospitals Treating Rhabdomyosarcoma

Risk calculators and risk factors for Rhabdomyosarcoma other imaging findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Shadan Mehraban, M.D.[2]

Overview

Positron emission tomography (PET) scanning and bone scan are usually used for assessment of metastatic lesion in rhabdomyosarcoma. There are no associated findings regarding these studies in rhabdomyosarcoma.

Other Imaging Findings

Positron emission tomography (PET) scanning

Bone Scan

References

  1. McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC (2005). "PET/CT in the evaluation of childhood sarcomas". AJR Am J Roentgenol. 184 (4): 1293–304. doi:10.2214/ajr.184.4.01841293. PMID 15788613.
  2. Völker T, Denecke T, Steffen I, Misch D, Schönberger S, Plotkin M; et al. (2007). "Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial". J Clin Oncol. 25 (34): 5435–41. doi:10.1200/JCO.2007.12.2473. PMID 18048826.
  3. Weiss AR, Lyden ER, Anderson JR, Hawkins DS, Spunt SL, Walterhouse DO; et al. (2013). "Histologic and clinical characteristics can guide staging evaluations for children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee". J Clin Oncol. 31 (26): 3226–32. doi:10.1200/JCO.2012.44.6476. PMC 3757291. PMID 23940218.

Template:WH Template:WS